The role of technology in reducing health care costs. Phase II and phase III.
Craft, Richard Layne, II, John Cilke, Raymond C. Parks, Donald R. Funkhouser, Michael Tebo, Martin Murphy, Marion Michael Hightower, Linda Gallagher, Rudy Garcia · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) · 2004
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) · Office of Scientific and Technical Information · report · 2004
Abstract
In Phase I of this project, reported in SAND97-1922, Sandia National Laboratories applied a systems approach to identifying innovative biomedical technologies with the potential to reduce U.S. health care delivery costs while maintaining care quality. The effort provided roadmaps for the development and integration of technology to meet perceived care delivery requirements and an economic analysis model for development of care pathway costs for two conditions: coronary artery disease (CAD) and benign prostatic hypertrophy (BPH).
Phases II and III of this project, which are presented in this report, were directed at detailing the parameters of telemedicine that influence care delivery costs and quality. These results were used to identify and field test the communication, interoperability, and security capabilities needed for cost-effective, secure, and reliable health care via telemedicine.
Open the resolved locator · 10.2172/970293
Metadata licence: OpenAlex metadata (CC0)